30 Sept 2026, 16:22
Company Update—
NYRNYRADA INC.
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 09:20
Securities Administration—
25 Sept 2026, 09:17
Securities Administration—
21 Sept 2026, 09:31
Securities Administration—
21 Sept 2026, 09:31
Securities Administration—
21 Sept 2026, 09:31
Securities Administration—
21 Sept 2026, 09:31
Securities Administration—
21 Sept 2026, 09:31
Capital RaisingMS
21 Sept 2026, 09:31
Capital RaisingMS
17 Sept 2026, 09:14
Trading Halt / SuspensionMS
16 Sept 2026, 08:31
Presentations—
28 Aug 2026, 09:36
Substantial Holders—
24 Aug 2026, 16:52
Securities Administration—
24 Aug 2026, 16:50
Securities Administration—
21 Aug 2026, 08:50
Company UpdateMS
18 Aug 2026, 13:08
Financial Results—
18 Aug 2026, 13:08
Financial Results—
18 Aug 2026, 13:05
Financial ResultsMS
18 Aug 2026, 13:04
Company Administration—
5 Aug 2026, 10:01
Substantial Holders—
5 Aug 2026, 09:16
Company Update—
27 July 2026, 08:44
Quarterly ReportsMS
15 July 2026, 16:58
ASX QueryMS
15 July 2026, 16:39
Substantial Holders—
6 July 2026, 09:39
Company Update—
30 June 2026, 17:43
Securities Administration—
30 June 2026, 09:48
Securities Administration—
30 June 2026, 09:46
Securities Administration—
29 June 2026, 18:11
Securities Administration—
29 June 2026, 18:10
Securities Administration—
16 June 2026, 16:42
Securities Administration—
16 June 2026, 16:39
Securities Administration—
16 June 2026, 08:25
Director Interests—
16 June 2026, 08:24
Company Update—
4 June 2026, 09:39
Presentations—
3 June 2026, 13:39
Company Update—
29 May 2026, 09:45
Periodic Reports—
25 May 2026, 17:19
Securities Administration—
25 May 2026, 17:15
Securities Administration—
21 May 2026, 12:56
Letters & Addresses—
20 May 2026, 09:13
Company UpdateMS
19 May 2026, 16:54
Trading Halt / SuspensionMS
19 May 2026, 15:37
Trading Halt / SuspensionMS
19 May 2026, 15:10
Company UpdateMS
22 Apr 2026, 12:30
Company Update—
15 Apr 2026, 08:45
Quarterly ReportsMS
20 Mar 2026, 08:37
Presentations—
19 Mar 2026, 09:55
Company Update—
9 Mar 2026, 17:17
Director Interests—
20 Feb 2026, 17:10
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 16:22 | Nyrada US Patent for Xolatryp Granted | Company Update | — | 11001 | |
| 25 Sept 2026, 09:20 | Cleansing Statement | Securities Administration | — | 06018 | |
| 25 Sept 2026, 09:17 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Cap Raise Deck-Building the Future of TRPC-based Therapies | Capital Raising | MS | 03026, 06003, 06017 | |
| 21 Sept 2026, 09:31 | Nyrada Successfully Raises AU$12.0 Million Via Placement | Capital Raising | MS | 06003, 06017, 09014 | |
| 17 Sept 2026, 09:14 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 Sept 2026, 08:31 | Investor Presentation- Evans&Partners Small Cap Healthcare | Presentations | — | 03026 | |
| 28 Aug 2026, 09:36 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 24 Aug 2026, 16:52 | Cleansing Statement | Securities Administration | — | 06018 | |
| 24 Aug 2026, 16:50 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 21 Aug 2026, 08:50 | Xolatryp Demonstrates Cardioprotection in Preclinical Study | Company Update | MS | 11001 | |
| 18 Aug 2026, 13:08 | Nyrada Full Year Results FY2026 | Financial Results | — | 03003 | |
| 18 Aug 2026, 13:08 | Annual Report for year ended 30 June 2026 | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 18 Aug 2026, 13:05 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 18 Aug 2026, 13:04 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 5 Aug 2026, 10:01 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 5 Aug 2026, 09:16 | CSANZ26 Conference Poster | Company Update | — | 11001 | |
| 27 July 2026, 08:44 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 16:58 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 15 July 2026, 16:39 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 6 July 2026, 09:39 | PROTECT-MI Phase IIa Clinical Trial Update No 2 | Company Update | — | 11001 | |
| 30 June 2026, 17:43 | Notification of cessation of securities - NYR | Securities Administration | — | 06027 | |
| 30 June 2026, 09:48 | Cleansing Statement | Securities Administration | — | 06018 | |
| 30 June 2026, 09:46 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 29 June 2026, 18:11 | Cleansing Statement | Securities Administration | — | 06018 | |
| 29 June 2026, 18:10 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 16 June 2026, 16:42 | Cleansing Statement | Securities Administration | — | 06018 | |
| 16 June 2026, 16:39 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 16 June 2026, 08:25 | Change of Director's Interest Notice - JB | Director Interests | — | 02009 | |
| 16 June 2026, 08:24 | PROTECT-MI Phase IIa Clinical Trial Update | Company Update | — | 11001 | |
| 4 June 2026, 09:39 | Investor Presentation | Presentations | — | 03026 | |
| 3 June 2026, 13:39 | Nyrada Successfully Completes Cardioprotection Pilot Study | Company Update | — | 11001 | |
| 29 May 2026, 09:45 | Nyrada Receives A$2.455M R&D Tax Incentive Rebate | Periodic Reports | — | 03014 | |
| 25 May 2026, 17:19 | Cleansing Statement | Securities Administration | — | 06018 | |
| 25 May 2026, 17:15 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 21 May 2026, 12:56 | Upcoming Expiry of Unlisted Options | Letters & Addresses | — | 06009, 16001 | |
| 20 May 2026, 09:13 | Xolatryp Enhances Anthracycline Anti-Tumour Efficacy | Company Update | MS | 09014, 11001 | |
| 19 May 2026, 16:54 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 19 May 2026, 15:37 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 19 May 2026, 15:10 | Nyrada Receives Notice of Allowance for Xolatryp US Patent | Company Update | MS | 11001 | |
| 22 Apr 2026, 12:30 | First Site Activated in Nyradas PROTECT-MI Phase IIa Trial | Company Update | — | 11001 | |
| 15 Apr 2026, 08:45 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 20 Mar 2026, 08:37 | Presentation - ASX SMIDCaps Conference | Presentations | — | 03026 | |
| 19 Mar 2026, 09:55 | Nyrada PROTECT-MI Phase IIa Trial To Commence | Company Update | — | 11001 | |
| 9 Mar 2026, 17:17 | Change of Director's Interest Notice - JM | Director Interests | — | 02009 | |
| 20 Feb 2026, 17:10 | Director Options Issue | Securities Administration | — | 06009 |
1–50 of 149
1 / 3